当前位置:Public Access >页面
Chinese/English
Efficacy of pirfenidone in the prevention and management of oral mucositis in nasopharyngeal carcinoma patients: a phase 2 multi-institutional trial

ChiCTR注册号:

Reg No. in ChiCTR:

PID: 205779

研究题目:

Efficacy of pirfenidone in the prevention and management of oral mucositis in nasopharyngeal carcinoma patients: a phase 2 multi-institutional trial

Study title:

Efficacy of pirfenidone in the prevention and management of oral mucositis in nasopharyngeal carcinoma patients: a phase 2 multi-institutional trial

 注册状况:

 Registration:

True

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

057188128202

电子邮件

Email

jinting@zjcc.org.cn

通讯地址:

杭州市拱墅区半山东路1号

Address:

No.1 Banshangdong Road, Gongshu District, Hangzhou City

邮政编码

Postcode

310022

项目负责人所有单位:

浙江省肿瘤医院

Institution:

Zhejiang Cancer Hospital

批准本研究的伦理委员会名称:

浙江省肿瘤医院医学伦理委员会

Name of the ethic committee:

the institutional ethics committee of Zhejiang Ca

研究疾病:

鼻咽癌

Study Ailment:

nasopharygeal carcinoma

研究所处阶段:

Study phase:

Post-market

研究类型:

Type of Study:

Therapy Study

研究团队:

金祁峰 花永虹 李辉章 娄鹏荣 何慧娟 田智峰 宋斌斌 吴峥 吕仙梅 许昀 龚晓昌

Research team:

Jin Qi-feng Hua Yong-hong Li Hui-zhang Lou Peng-rong He hui-juan Tian Zhi-feng Song Bin-bin Wu Zheng Lv Xian-mei Xu Yun Gong Xiao-chang

研究实施地点:

Site of Study:

国家(地区):

中国

省(直辖市):

浙江省

市(区县):

杭州市

Country/Area:

china

Province:

zhejiang

City:

hangzhou
单位 浙江省肿瘤医院
Institution zhejiang cancer hospital

预计起止时间:

Planned Duration:

2024/3/14 0:00:00-2026/3/31 0:00:00